After This Week’s 2.74% Gain In Nu Skin Enterprises, Inc (NYSE: NUS), We Just Learned Something New

Nu Skin Enterprises, Inc (NYSE:NUS)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting 1.18. At the close of trading, the stock’s price was $7.50, to imply a decrease of -2.47% or -$0.19 in intraday trading. The NUS share’s 52-week high remains $20.75, putting it -176.67% down since that peak but still an impressive 20.67% since price per share fell to its 52-week low of $5.95. The company has a valuation of $372.83M, with an average of 0.78 million shares in intraday trading volume over the past 10 days and average of 1.11 million shares over the past 3 months.

Nu Skin Enterprises, Inc (NYSE:NUS) trade information

After registering a -2.47% downside in the last session, Nu Skin Enterprises, Inc (NUS) has traded red over the past five days. The 5-day price performance for the stock is 2.74%, and 15.74% over 30 days. With these gigs, the year-to-date price performance is -61.38%. Short interest in Nu Skin Enterprises, Inc (NYSE:NUS) saw shorts transact 1.79 million shares and set a 2.22 days time to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The extremes give us $11 and $11 for target low and target high price respectively. As such, NUS has been trading -46.67% off suggested target high and -46.67% from its likely low.

Nu Skin Enterprises, Inc (NUS) estimates and forecasts

Looking at statistics comparing Nu Skin Enterprises, Inc share performance against respective industry, we note that the company has underperformed competitors. Nu Skin Enterprises, Inc (NUS) shares are -43.35% down over the last 6 months, with its year-to-date growth rate lower than industry average at -61.08% against -1.30%. The rating firms project that company’s revenue will shrink -12.23% compared to the previous financial year.

Revenue forecast for the current quarter as set by 3 analysts is 439.26M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 415.2M.Earnings reports from the last fiscal year show that sales brought in 488.64M and 417.31M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -10.11% before dropping -0.51% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -39.68% for the past 5-year period. While 2024 is set for a -63.08% return in earnings, projections for the next 5 years are at 6.81% annually.

NUS Dividends

Nu Skin Enterprises, Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Nu Skin Enterprises, Inc has a forward dividend ratio of 0.24, with the share yield ticking at 3.20% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 4.8%.

Nu Skin Enterprises, Inc (NYSE:NUS)’s Major holders

Nu Skin Enterprises, Inc insiders hold 2.29% of total outstanding shares, with institutional holders owning 81.19% of the shares at 83.10% float percentage. In total, 81.19% institutions holds shares in the company, led by BLACKROCK INC. As of 2024-06-30, the company held over 8.12 million shares (or 16.3966% of shares), all amounting to roughly $85.61 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 6.55 million shares, or about 13.214% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $68.99 million.